A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the Use of CUSA-081 for Dysfunctional Central Venous Access Devices (CVADs)
Clinical Trial Grant
Administered By
Anesthesiology, Critical Care Medicine
Awarded By
Chiesi Farmaceutici SPA
Start Date
March 27, 2020
End Date
March 31, 2024
Administered By
Anesthesiology, Critical Care Medicine
Awarded By
Chiesi Farmaceutici SPA
Start Date
March 27, 2020
End Date
March 31, 2024